Experience of using a probiotic containing Lactobacillus reuteri B-9448 in children with acute infectious gastroenteritis
Open Access
- 26 March 2024
- journal article
- research article
- Published by LLC Global Media Technology in Archives of Pediatrics and Pediatric Surgery
- Vol. 2 (1) , 104-112
Abstract
The article presents literature data on the relationship of disorders of the gastrointestinal tract with its microbiota in acute intestinal infections, as well as information on various beneficial properties of the probiotic microorganism Lactobacillus reuteri, including antagonistic effects on pathogenic and opportunistic pathogens, anti-inflammatory and immunomodulatory effects. The clinical and laboratory effectiveness of the use of a probiotic containing the Lactobacillus reuteri B-9448 strain in children with acute infectious gastroenteritis hospitalized. It was found that patients who received this probiotic in complex therapy spent significantly fewer bed days in the hospital compared to children who were not prescribed probiotic. At the same time, no undesirable side effects were registered in the group of patients treated with Lactobacillus reuteri B-9448, which indicates its safety.Keywords
This publication has 12 references indexed in Scilit:
- Efficacy of Lactobacillus reuteri in clinical practiceRussian Journal of Woman and Child Health, 2021
- MICROBES INSIDE OUR BODIES: CASUAL COMPANIONS, OR PREREQUISITE FOR OUR SURVIVAL? OR WHY PROBIOTICS ARE NEEDED IN INFANT FORMULAEPediatria. Journal named after G.N. Speransky, 2020
- Role of Lactobacillus reuteri in Human Health and DiseasesFrontiers in Microbiology, 2018
- WHAT DO WE KNOW TODAY ABOUT LACTOBACILLUS REUTERI?Meditsinskiy sovet = Medical Council, 2018
- Effect of Lactobacillus reuteri on Cell Viability and PGE2 Production in Human Gingival FibroblastsProbiotics and Antimicrobial Proteins, 2016
- Diarrhea in Preschool Children and Lactobacillus reuteri: A Randomized Controlled TrialPediatrics, 2014
- Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L . reuteri DSM 17938Applied and Environmental Microbiology, 2008
- The First Low Molecular Weight Antibiotic from Lactic Acid Bacteria: Reutericyclin, a New Tetramic AcidAngewandte Chemie International Edition, 2000
- Validation of the Probiotic Concept: Lactobacillus reuteri Confers Broad-spectrum Protection against Disease in Humans and AnimalsMicrobial Ecology in Health and Disease, 2000
- Production of a Broad Spectrum Antimicrobial Substance byLactobacillus reuteriMicrobial Ecology in Health and Disease, 1989